What is he best known for?
The fields of study he is best known for:
- Immune system
- Gene
- Antibody
Christian Münz mostly deals with Immunology, Immune system, Cell biology, Virology and T cell.
Christian Münz has researched Cell biology in several fields, including Autophagy, Antigen processing, Antigen presentation, Interleukin 21 and Interleukin 12.
His Autophagy study integrates concerns from other disciplines, such as Inflammation and Programmed cell death.
As a part of the same scientific family, he mostly works in the field of Virology, focusing on Cytotoxic T cell and, on occasion, Human leukocyte antigen.
His T cell research integrates issues from Antigen and Effector.
The concepts of his Chaperone-mediated autophagy study are interwoven with issues in MAP1LC3B, BECN1 and Neuroscience.
His most cited work include:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Guidelines for the use and interpretation of assays for monitoring autophagy (3242 citations)
- Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes (1951 citations)
What are the main themes of his work throughout his whole career to date?
Christian Münz spends much of his time researching Immunology, Cell biology, Immune system, Virology and Antigen.
The various areas that he examines in his Immunology study include Cytotoxic T cell and Interleukin 12.
Christian Münz interconnects Autophagy and Antigen processing, MHC class I, Antigen presentation, Major histocompatibility complex in the investigation of issues within Cell biology.
His research in Autophagy is mostly concerned with Autophagosome.
Many of his studies on Immune system apply to Multiple sclerosis as well.
The T cell study combines topics in areas such as Cancer research, CD8 and B cell.
He most often published in these fields:
- Immunology (55.84%)
- Cell biology (37.85%)
- Immune system (36.91%)
What were the highlights of his more recent work (between 2018-2021)?
- Immune system (36.91%)
- Epstein–Barr virus (22.08%)
- Immunology (55.84%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Immune system, Epstein–Barr virus, Immunology, Virus and T cell.
His work deals with themes such as Neuroinflammation and Post-transplant lymphoproliferative disorder, which intersect with Immune system.
His Epstein–Barr virus research incorporates elements of Immune control, Cytotoxic T cell, Cancer research and Lytic cycle.
He combines subjects such as Tumor Virus and Disease with his study of Immunology.
His T cell study combines topics from a wide range of disciplines, such as Phenotype and Priming, Antigen.
His study explores the link between Major histocompatibility complex and topics such as Acquired immune system that cross with problems in Cell biology.
Between 2018 and 2021, his most popular works were:
- Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) (345 citations)
- Latency and lytic replication in Epstein–Barr virus-associated oncogenesis (57 citations)
- Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) (38 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Gene
- Antibody
Christian Münz mostly deals with Virus, Immunology, Immune system, Epstein–Barr virus and Virology.
The study incorporates disciplines such as T cell, Lymphoproliferative disorders and Priming in addition to Virus.
His Immunology research is multidisciplinary, incorporating elements of Tumor Virus and Disease.
Specifically, his work in Immune system is concerned with the study of CD8.
His CD8 research includes themes of Endocytosis, Major histocompatibility complex and Cell biology.
His work carried out in the field of Virology brings together such families of science as CD34, CXCR4, In vitro and Antigen.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
